Rickman Alexis D, Hilyard Addison, Heckmann Bradlee L
Department of Cell Biology, Microbiology & Molecular Biology, University of South Florida, Tampa, FL, USA.
USF Health Byrd Alzheimer's Center and Neuroscience Institute, Morsani College of Medicine, Tampa, FL, USA.
Neural Regen Res. 2022 Feb;17(2):246-250. doi: 10.4103/1673-5374.317958.
Neuroinflammation and neurodegeneration are key components in the establishment and progression of neurodegenerative diseases including Alzheimer's Disease (AD). Over the past decade increasing evidence is emerging for the use of components of the canonical autophagy machinery in pathways that are characterized by LC3 lipidation yet are distinct from traditional macro-autophagy. One such pathway that utilizes components of the autophagy machinery to target LC3 to endosomes, a process termed LC3-associated endocytosis (LANDO), has recently been identified and regulates neuroinflammation. Abrogation of LANDO in microglia cells results in a propensity for elevated neuroinflammatory cytokine production. Using the well-established 5xFAD model of AD to interrogate neuroinflammatory regulation, impairment of LANDO through deletion of a key upstream regulator Rubicon or other downstream autophagy components, exacerbated disease onset and severity, while deletion of microglial autophagy alone had no measurable effect. Mice presented with robust deposition of the neurotoxic AD protein β-amyloid (Aβ), microglial activation and inflammatory cytokine production, tau phosphorylation, and aggressive neurodegeneration culminating in severe memory impairment. LANDO-deficiency impaired recycling of receptors that recognize Aβ, including TLR4 and TREM2. LANDO-deficiency alone through deletion of the WD-domain of the autophagy protein ATG16L, revealed a role for LANDO in the spontaneous establishment of age-associated AD. LANDO-deficient mice aged to 2 years presented with advanced AD-like disease and pathology correlative to that observed in human AD patients. Together, these studies illustrate an important role for microglial LANDO in regulating CNS immune activation and protection against neurodegeneration. New evidence is emerging that demonstrates a putative linkage between pathways such as LANDO and cell death regulation via apoptosis and possibly necroptosis. Herein, we provide a review of the use of the autophagy machinery in non-canonical mechanisms that alter immune regulation and could have significant impact in furthering our understanding of not only CNS diseases like AD, but likely beyond.
神经炎症和神经退行性变是包括阿尔茨海默病(AD)在内的神经退行性疾病发生和发展的关键组成部分。在过去十年中,越来越多的证据表明,经典自噬机制的组成部分在以LC3脂化为特征但不同于传统巨自噬的途径中发挥作用。最近发现了一种利用自噬机制的组成部分将LC3靶向内涵体的途径,这一过程称为LC3相关内吞作用(LANDO),它可调节神经炎症。小胶质细胞中LANDO的缺失会导致神经炎症细胞因子产生增加的倾向。利用成熟的AD 5xFAD模型来研究神经炎症调节,通过缺失关键上游调节因子Rubicon或其他下游自噬成分来损害LANDO,会加剧疾病的发作和严重程度,而单独缺失小胶质细胞自噬则没有可测量的影响。小鼠出现神经毒性AD蛋白β淀粉样蛋白(Aβ)的大量沉积、小胶质细胞活化和炎性细胞因子产生、tau蛋白磷酸化以及严重的神经退行性变,最终导致严重的记忆障碍。LANDO缺陷会损害识别Aβ的受体的再循环,包括Toll样受体4(TLR4)和触发受体表达的髓系细胞2(TREM2)。仅通过缺失自噬蛋白ATG16L的WD结构域导致LANDO缺陷,揭示了LANDO在年龄相关AD的自发发生中的作用。2岁的LANDO缺陷小鼠出现了与人类AD患者中观察到的情况相关的晚期AD样疾病和病理学特征。总之,这些研究说明了小胶质细胞LANDO在调节中枢神经系统免疫激活和预防神经退行性变方面的重要作用。新出现的证据表明,LANDO等途径与通过凋亡以及可能的坏死性凋亡进行的细胞死亡调节之间存在假定联系。在此,我们综述了自噬机制在非经典机制中的应用,这些机制改变免疫调节,不仅可能对我们进一步理解像AD这样的中枢神经系统疾病有重大影响,而且可能影响更广泛的领域。